SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-001110
Filing Date
2022-02-11
Accepted
2022-02-11 13:45:42
Documents
93
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q me-20211231.htm   iXBRL 10-Q 4833694
2 EX-10.1 me-ex10_1.htm EX-10.1 44264
3 EX-31.1 me-ex31_1.htm EX-31.1 29342
4 EX-31.2 me-ex31_2.htm EX-31.2 27182
5 EX-32.1 me-ex32_1.htm EX-32.1 19083
6 EX-32.2 me-ex32_2.htm EX-32.2 19092
  Complete submission text file 0000950170-22-001110.txt   18480144

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT me-20211231_def.xml EX-101.DEF 437448
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20211231.xsd EX-101.SCH 96055
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20211231_lab.xml EX-101.LAB 754025
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT me-20211231_cal.xml EX-101.CAL 65207
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20211231_pre.xml EX-101.PRE 614422
87 EXTRACTED XBRL INSTANCE DOCUMENT me-20211231_htm.xml XML 4294087
Mailing Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086
Business Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39587 | Film No.: 22619115
SIC: 2834 Pharmaceutical Preparations